|
|
Direct-to-Consumer (DTC) genomic tests are widely marketed to consumers as tools of “empowering personal choices about their health and well-being”. However there are risks of making complex medical decision without adequate clinical understanding or direction from health providers. This symposium will provide a lively discussion on the current controversies in DTC testing.
|